Department of Hematopoiesis, Sanquin Research, 1066 CX Amsterdam, The Netherlands.
Landsteiner Laboratory, Oncode Institute, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6686-6696. doi: 10.1073/pnas.1913940117. Epub 2020 Mar 11.
Cytotoxic CD8 T cells can effectively kill target cells by producing cytokines, chemokines, and granzymes. Expression of these effector molecules is however highly divergent, and tools that identify and preselect CD8 T cells with a cytotoxic expression profile are lacking. Human CD8 T cells can be divided into IFN-γ- and IL-2-producing cells. Unbiased transcriptomics and proteomics analysis on cytokine-producing fixed CD8 T cells revealed that IL-2 cells produce helper cytokines, and that IFN-γ cells produce cytotoxic molecules. IFN-γ T cells expressed the surface marker CD29 already prior to stimulation. CD29 also marked T cells with cytotoxic gene expression from different tissues in single-cell RNA-sequencing data. Notably, CD29 T cells maintained the cytotoxic phenotype during cell culture, suggesting a stable phenotype. Preselecting CD29-expressing MART1 TCR-engineered T cells potentiated the killing of target cells. We therefore propose that CD29 expression can help evaluate and select for potent therapeutic T cell products.
细胞毒性 CD8 T 细胞可以通过产生细胞因子、趋化因子和颗粒酶来有效杀死靶细胞。然而,这些效应分子的表达具有高度的差异性,缺乏能够识别和预先选择具有细胞毒性表达谱的 CD8 T 细胞的工具。人 CD8 T 细胞可以分为产生 IFN-γ和 IL-2 的细胞。对产生细胞因子的固定 CD8 T 细胞进行的无偏转录组学和蛋白质组学分析表明,IL-2 细胞产生辅助细胞因子,而 IFN-γ 细胞产生细胞毒性分子。IFN-γ T 细胞在刺激前就已经表达表面标记 CD29。CD29 还标记了单细胞 RNA 测序数据中来自不同组织的具有细胞毒性基因表达的 T 细胞。值得注意的是,CD29 T 细胞在细胞培养过程中保持细胞毒性表型,表明其具有稳定的表型。预先选择表达 CD29 的 MART1 TCR 工程 T 细胞增强了对靶细胞的杀伤能力。因此,我们提出 CD29 的表达可以帮助评估和选择有效的治疗性 T 细胞产品。